Skip to main content

Table 1 Summary of patient clinical information from 7 GEO databases

From: The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia

 

Overall

GSE10358

GSE12417

GSE37642

GSE66525

GSE6891

GSE71014

GSE8970

n

1799

300

242

562

22

536

104

33

Platform (%)

 GPL10558

104 (5.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

104 (100.0)

0 (0.0)

 GPL11532

22 (1.2)

0 (0.0)

0 (0.0)

0 (0.0)

22 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

 GPL570

1055 (58.6)

300 (100.0)

79 (32.6)

140 (24.9)

0 (0.0)

536 (100.0)

0 (0.0)

0 (0.0)

 GPL96

618 (34.4)

0 (0.0)

163 (67.4)

422 (75.1)

0 (0.0)

0 (0.0)

0 (0.0)

33 (100.0)

Age group, year/n (%)

 < 60

931 (66.0)

53 (58.2)

119 (49.2)

297 (52.8)

14 (63.6)

448 (97.4)

0 (0.0)

0 (0.0)

 ≥ 60

479 (34.0)

38 (41.8)

123 (50.8)

265 (47.2)

8 (36.4)

12 (2.6)

0 (0.0)

33 (100.0)

WBC group, × 109 L−1/n (%)

 < 10

567 (80.1)

4 (4.4)

0 (0.0)

562 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (3.0)

 ≥ 10

141 (19.9)

87 (95.6)

0 (0.0)

0 (0.0)

22 (100.0)

0 (0.0)

0 (0.0)

32 (97.0)

PB blasts/n (%)

 < 40

50 (44.2)

48 (52.7)

0 (0.0)

0 (0.0)

2 (9.1)

0 (0.0)

0 (0.0)

0 (0.0)

 ≥ 40

63 (55.8)

43 (47.3)

0 (0.0)

0 (0.0)

20 (90.9)

0 (0.0)

0 (0.0)

0 (0.0)

BM blasts/n (%)

 < 50

1638 (97.9)

265 (88.3)

242 (100.0)

562 (100.0)

0 (0.0)

536 (100.0)

0 (0.0)

33 (100.0)

 ≥ 50

35 (2.1)

35 (11.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

OS status/n (%)

 Alive

449 (25.1)

46 (15.3)

92 (38.0)

147 (26.6)

0 (0.0)

128 (23.9)

36 (34.6)

0 (0.0)

 Dead

884 (49.4)

45 (15.0)

150 (62.0)

406 (73.4)

0 (0.0)

215 (40.1)

68 (65.4)

0 (0.0)

 NA

457 (25.5)

209 (69.7)

0 (0.0)

0 (0.0)

22 (100.0)

193 (36.0)

0 (0.0)

33 (100.0)

  1. Abbreviations: WBC, white blood cell; BM, bone marrow; PB, peripheral blood; OS, overall survival